Influence of Industry on Renal Guideline Development
Open Access
- 1 January 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 2 (1) , 3-7
- https://doi.org/10.2215/cjn.02170606
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- II. Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease in AdultsAmerican Journal of Kidney Diseases, 2006
- Executive SummaryAmerican Journal of Kidney Diseases, 2006
- Conflict of Interest: Can We Minimize Its Influence in the Biomedical Literature?The Journal of the American Board of Family Medicine, 2005
- The Proliferation of Clinical Practice Guidelines: Professional Development or Medicine-by-Numbers?The Journal of the American Board of Family Medicine, 2005
- Extent and impact of industry sponsorship conflicts of interest in dermatology researchJournal of the American Academy of Dermatology, 2005
- Doctors and Drug CompaniesNew England Journal of Medicine, 2004
- Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJBMJ, 2002
- Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical IndustryJAMA, 2002
- IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000American Journal of Kidney Diseases, 2001
- The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and EpoetinNew England Journal of Medicine, 1998